Cycling and Tai Chi Chuan exercises exert greater immunomodulatory effect on surface antigen expression of human hepatitis B virus

Chinese Medical Journal

Volumn 121, Issue 21, 2008, Pages 2172-2179

  Chen, Yu Yawn ^a   Chiang, Jasson ^b   Chen, Yu Jen ^b,c   Chen, Kung Tung ^d   Yang, Rong Sen ^e   Lin, Jaung Geng ^f  

^a NATIONAL TAIWAN UNIVERSITY OF SPORT   (Taiwan)

^b CHINESE CULTURE UNIVERSITY   (Taiwan)

^c MACKAY MEMORIAL HOSPITAL   (Taiwan)

^d MINGHSIN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Competitive cyclists; Hepatitis B surface antigens; Immunomodulatory

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AEROBIC EXERCISE; ANTIGEN EXPRESSION; ARTICLE; COLLEGE STUDENT; CONTROLLED STUDY; CYCLING; CYTOKINE RELEASE; FEMALE; HEPATITIS B VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; MALE; MIDDLE AGED; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; TAI CHI; EXERCISE; OXYGEN CONSUMPTION; PHYSIOLOGY;

ADULT; EXERCISE; HEPATITIS B SURFACE ANTIGENS; HUMANS; INTERFERON-GAMMA; MALE; OXYGEN CONSUMPTION; TAI JI; TUMOR NECROSIS FACTOR-ALPHA;

EID: 58149355312     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200811010-00013     Document Type: Article

References (44)

1. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis 2002; 2: 395-403.
2. Kane MA. Global status of hepatitis B immunisation. Lancet 1996; 348: 696.
3. Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988; 61: 1942-1956.
4. Nieman DC, Johanssen LM, Lee JW, Cermak J, Arabatzis K. Infectious episodes in runners before and after the Los Angeles Marathon. J Sports Med Phys Fitness 1990; 30: 316-328.
5. Peters EM, Bateman ED. Ultramarathon running and upper respiratory tract infections. South Med J 1983; 64: 582-584.
6. Nieman DC, Nehlsen-Cannarella SL, Markoff PA. The effects of moderate exercise training on natural killer cells and acute upper respiratory tract infections. Int J Sports Med 1990; 11: 467-473.
7. Gong LS, Qian JN, Zhang JS, Yang Q, Jiang J, Tao Q, et al. Changes in heart rate and electrocardiogram during Taijiquan exercise: analysis by telemetry in 100 subjects. Chin Med J 1981; 94: 589-592.
8. Kohut ML, Arntson BA, Lee W, Rozeboom K, Yoon KJ, Cunnick JE, et al. Moderate exercise improves antibody response to influenza immunization in older adults. Vaccine 2004; 22: 2298-2306.
9. Davis JM, Murphy EA, Brown AS, Carmichael MD, Ghaffa A, Maye EP. Effects of moderate exercise and oat β-glucan on innate immune function and susceptibility to respiratory infection. Am J Physiol Regul Integr Comp Physiol 2004: 286: R366-R372.
10. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999; 17: 189-220.
11. Schindler C, Brutsaert S. Interferons as a paradigm for cytokine signal transduction. Cell Mol Life Sci 1999; 55: 1509-1522.
12. Chetverikova LK, Frolov BA, Kramskaya TA, Polyak RYa. Experimental influenza infection: influence of stress. Acta Virol 1987; 31: 424-433.
13. Reyes MP, Lerner AM. Interferon and neutralizing antibody in sera of exercised mice with coxsackievirus B-3 myocarditis. Proc Soc Exp Biol Med 1976; 151: 333-338.
14. Solomon GF, Merigan TC, Levine S. Variation in adrenal cortical hormones within physiologic ranges, stress and interferon production in mice. Proc Soc Exp Biol Med 1967; 126: 74-79.
15. Suri D, Schilling R, Lopes AR, Mullerova I, Colucci G, Williams R, et al. Non-cytolytic inhibition of hepatitis B virus replication in human hepatocytes. J Hepatol 2001; 35: 790-797.
16. Moldoveanu AI, Shephard RJ, Shek PN. Exercise elevates plasma levels but not gene expression of IL-1beta, IL-6, and TNF-alpha in blood mononuclear cells. J Appl Physiol 2000; 89: 1499-1504.
17. Ren F, Hino K, Yamaguchi Y, Funatsuki K, Hayashi A, Ishiko H, et al. Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection. J Med Virol 2003; 71: 376-384.
18. Haria M, Benfield P. Interferon-alpha-2a review of its pharmacological properties and therapeutic use in the management of viral hepatitis. Drugs 1995; 50: 873-896.
19. Chiang J, Huang YW, Chen ML, Wang SY, Huang AC, Chen YJ. Comparison of anti-leukemic immunity against U937 cells in endurance athletes versus sedentary controls. Int J Sports Med 2000; 21: 602-607.
20. Wang SY, Hsu ML, Hsu HC, Tzeng CH, Lee SS, Shiao MS, et al. The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages Tlymphocytes. Int J Cancer 1997; 70: 699-705.
21. Chen YY, Chang HM. Antiproliferative and differentiating effects of polysaccharide fraction from Fu-Ling (Poria cocos) on human leukemic U937 and HL-60 cells source. Food Chem Toxicol 2004; 42: 759-769.
22. Chen YJ, Shiao MS, Lee SS, Wang SY. Effect of Cordyceps sinensis on the proliferation and differentiation of human leukemic U937 cells. Life Sci 1997; 60: 2349-2359.
23. Liao HF, Chiang LM, Yen CC, Chen YY, Zhuang RR, Lai LY, et al. Effect of a periodized exercise training and active recovery program on antitumor activity and development of dendritic cells. J Sports Med Phys Fitness 2006; 46: 307-314.
24. Mcclary H, Koch R, Chisari FV, Guidotti LG. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J Virol 2000; 74: 2255-2264.
25. Geneva-Popova M, Murdjeva M. Study on proinflammatory cytokines (IL-1 beta, IL-6, TNF-alpha) and IL-2 in patients with acute hepatitis B. Folia Medica (Plovdiv) 1999; 41: 478-481.
26. Knowles BB, Howe CC, Aden DP. Human hepatocellular carcinomacell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 1980; 209: 497-501.
27. Twist EM, Clark HF, Aden DP, Knowles BB, Plotkin SA. Integration pattern of hepatitis B virus DNA sequences in human hepatoma celllines. J Virol 1981; 37: 239-243.
28. Mosmann T. Rapid colorimetric assay for cellular growth and survival, application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 69: 55-63.
29. Chisari FV. Cytotoxic T cells and viral hepatitis. J Clin Invest 1997; 99: 1472-1477.
30. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-1745.
31. Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, et al. Taiwan community-based cancer screening project group Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002; 347: 168-174.
32. Czaja AJ. Serologic markers of hepatitis A and B in acute and chronic liver disease. Mayo Clin Proc 1979; 54: 721-732.
33. Lin SJ, Shu PY, Chang C, Ng AK, Hu CP. IL-4 suppresses the expression and the replication of hepatitis B virus in the hepatocellular carcinoma cell line Hep3B. J Immunol 2003; 171: 4708-4716.
34. Chen HC, Chou CK, Sun CM, Yeh SF. Suppressive effects of destruxin B on hepatitis B virus surface antigen gene expression in human hepatoma cells. Antiviral Res 1997; 34: 137-144.
35. Chen HC, Chou CK, Lee SD, Wang JC, Yeh SF. Active compounds from Saussurea lappa Clarks that suppress hepatitis B virus surface antigen gene expression in human hepatoma cells. Antiviral Res 1995; 27: 99-109.
36. Lowder T, Padgett DA, Woods JA. Moderate exercise protects mice from death due to influenza virus. Brain Behav Immun 2005; 19: 377-380.
37. Bonino F, Rosina F, Rizzetto M, Rizzi R, Chiaberge E, Tardanico R, et al. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. Gastroenterology 1986: 90: 1268-1273.
38. Mahrle G, Schulze HJ. Recombinant interferon-gamma (rIFN-gamma) in dermatology. J Invest Dermatol 1990: 95: 132S-137S.
39. Shinkai S, Kohno H, Kimura K, Komura T, Asai H, Inai R, et al. Physical activity and immune senescence in men. Med Sci Sports Exerc 1995; 27: 1516-1526.
40. Schultz U, Chisari FV. Recombinant duck interferon gamma inhibits duck hepatitis B virus replication in primary hepatocytes. J Virol 1999; 73: 3162-3168.
41. Sheron N, Lau J, Daniels H, Goka J, Eddleston A, Alexander GJ, et al. Increased production of tumour necrosis factor alpha in chronic hepatitis B virus infection. J Hepatol 1991; 12: 241-245.
42. Biermer M, Puro R, Schneider RJ. Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid integrity through activation of NF-kappa B. J Virol 2003; 77: 4033-4042.
43. Romero R, Lavine JE. Cytokine inhibition of the hepatitis B virus core promoter. Hepatology 1996; 23: 17-23.
44. Leibson PJ, Laszlo MH, Hayward AR. Inhibition of herpes simplex virus type 1 replication in fibroblast cultures by human blood mononuclear cells. J Virol 1986; 57: 976-982.